aluminum foil
HUMAN HEALTH RISK ASSESSMENT FOR ALUMINIUM,
ALUMINIUM OXIDE, AND ALUMINIUM HYDROXIDE
Daniel Krewski1,2, Robert A Yokel3, Evert Nieboer4, David Borchelt5, Joshua Cohen6, Jean Harry7, Sam Kacew2,8, Joan Lindsay9, Amal M Mahfouz10, and Virginie Rondeau11
1 Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
2 McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada
3 College of Pharmacy and Graduate Center for Toxicology, University of Kentucky Medical Center, Kentucky, USA
4 Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada and Institute of Community Medicine, University of Tromsø, Norway
5 SantaFe Health Alzheimer’s Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, USA
6Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, USA
7National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA
8Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
9Aging-Related Diseases Section, Surveillance Division, Public Health Agency of Canada, Ottawa, Ontario, Canada
10United States Environmental Protection Agency, Washington DC, USA
11INSERM E0338 (Biostatistic), Université Victor Segalen Bordeaux 2, Bordeaux, France
Keywords
aluminium; aluminium oxide; aluminium hydroxide; speciation; human health; neurotoxicity; exposure; toxicokinetics; toxicology; epidemiology; Alzheimer’s disease; risk assessment (Read Full Report)
